share_log

Stephens & Co. Reiterates Overweight on Steris, Maintains $260 Price Target

Benzinga ·  Aug 8 04:02  · Ratings

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $260 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment